The ban on sales of alcohol and tobacco to minors
Tendances n°87, OFDT, 4 p.
The Hospital, Patients, Health and Territories (French) law of July 21, 2009 (the so-called «HPST law») established a ban on the sale of alcoholic beverages and tobacco products to all minors. The prior regulations had banned the sale of alcoholic beverages and tobacco to minors under the age of 16. By expanding the restrictions to minors aged 16-17, legislators hoped to provide a firm response to the risks related to recent trends in alcohol consumption («massive alcohol abuse») and tobacco smoking among adolescents. In addition, these legislative provisions fall within the scope of guidelines issued by the World Health Organisation (WHO), which recommends implementing validated public health strategies, including banning the sale of alcohol and tobacco to minors. The National Health Directorate (DGS) commissioned the French Monitoring Centre for Drugs and Drug Addiction (OFDT) to conduct an evaluation of how the ban on sales to minors was being implemented and what the impact of the ban was on prevalence and accessibility. To do this, the OFDT used several existing surveys and conducted two ad hoc studies. This issue of Tendances provides a summary of the key results of this assessment.
Cristina Díaz Gómez, Aurélie Lermenier, Maitena Milhet
Download the PDF file (750 Ko)
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.
Country drug reports 2019
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.